Stephane heads business development and licensing at MIP Diagnostics to drive the adoption of Molecularly Imprinted Polymers in market applications such as Bioprocessing for Therapeutics, Food and Beverage; Oil & Gas and Fundamental Research. He particularly enjoys working with customers, large and small, to help them solve their problems and achieve their development and supply chain goals.

Stephane brings extensive commercial experience in the Life Science and IVD sectors developed over 22 years working for organisations such as BBI Solutions, SCIPAC and Life Technologies. He has significant expertise in immuno-reagents such as antibodies, antigens and serum & plasma; as well as a broad knowledge of immunoassay development and cell culture supplements. 

Since 1999, Stephane has held commercial executive and leadership roles in which he has built business platforms to launch new products and technologies to market in response to customer demand and/or to address unmet needs. His success in these areas has been rewarded with several business accolades over the years such as The Queen’s Awards for International Trade and for Innovation.